XTX Topco Ltd

Position in NUVB — Nuvation Bio Inc.

CIK 1828301 LONDON, X0

Position in NUVB

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$987,154

+$675,490 QoQ

Shares Held

230,106

+561.5% QoQ

Ownership

0.066%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

XTX Topco Ltd holds $287,762,779 across 374 Biotechnology names. NUVB ranks #83 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	255,431	$7,075,438
2	VRTX	Vertex Pharmaceuticals Inc / Ma	15,632	$6,980,313
3	IONS	Ionis Pharmaceuticals Inc	80,519	$6,046,171
4	EXEL	Exelixis, Inc.	134,413	$5,764,973
5	NUVL	Nuvalent, Inc.	53,354	$5,466,117
6	AGIO	Agios Pharmaceuticals, Inc.	160,880	$5,442,570
7	BMRN	Biomarin Pharmaceutical Inc	93,609	$5,287,972
8	RYTM	Rhythm Pharmaceuticals, Inc.	59,502	$5,174,888

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$987,154	230,106	+561.5%	Shares	Defined	2026-05-15
2025-12-31	$311,664	34,784	-67.5%	Shares	Defined	2026-02-17
2025-09-30	$395,678	106,940	-7.6%	Shares	Defined	2025-11-14
2025-06-30	$225,655	115,721	+108.3%	Shares	Defined	2025-08-12
2025-03-31	$97,792	55,564	+424.9%	Shares	Defined	2025-05-08
2024-12-31	$28,156	10,585	-92.0%	Shares	Defined	2025-02-13
2024-09-30	$302,346	132,029	-24.3%	Shares	Defined	2024-11-14
2024-03-31	$635,143	174,490	-28.6%	Shares	Defined	2024-05-13
2023-12-31	$368,802	244,240	+819.1%	Shares	Defined	2024-02-13
2023-09-30	$35,609	26,574	-20.8%	Shares	Defined	2023-11-13
2023-06-30	$60,395	33,553	-32.3%	Shares	Defined	2023-08-14
2023-03-31	$82,292	49,574	-0.7%	Shares	Defined	2023-05-12
2022-12-31	$95,811	49,902	-11.4%	Shares	Defined	2023-02-14
2022-06-30	$182,434	56,307	—	Shares	Defined	2022-08-15
No filing history on record for this holder in this stock.